Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 232

1.

Paraoxonase 1 polymorphisms are not related with the risk for multiple sclerosis.

Martínez C, García-Martín E, Benito-León J, Calleja P, Díaz-Sánchez M, Pisa D, Alonso-Navarro H, Ayuso-Peralta L, Torrecilla D, Agúndez JA, Jiménez-Jiménez FJ.

Neuromolecular Med. 2010 Sep;12(3):217-23. doi: 10.1007/s12017-009-8095-9. Epub 2009 Oct 14.

PMID:
19826962
2.

Paraoxonase 1 (PON1) polymorphisms and risk for migraine.

García-Martín E, Martínez C, Serrador M, Alonso-Navarro H, Navacerrada F, Agúndez JA, Jiménez-Jiménez FJ.

J Neurol. 2010 Sep;257(9):1482-5. doi: 10.1007/s00415-010-5551-2. Epub 2010 Apr 21.

PMID:
20407783
3.

Two common nonsynonymous paraoxonase 1 (PON1) gene polymorphisms and brain astrocytoma and meningioma.

Martínez C, Molina JA, Alonso-Navarro H, Jiménez-Jiménez FJ, Agúndez JA, García-Martín E.

BMC Neurol. 2010 Aug 19;10:71. doi: 10.1186/1471-2377-10-71.

4.

Paraoxonase (PON)1 192R allele carriage is associated with reduced risk of inflammatory bowel disease.

Karban A, Hartman C, Eliakim R, Waterman M, Nesher S, Barnett-Griness O, Shamir R.

Dig Dis Sci. 2007 Oct;52(10):2707-15. Epub 2007 Apr 12.

PMID:
17436100
5.

Paraoxonase 1 (PON1) polymorphisms and risk for essential tremor.

García-Martín E, Martínez C, Alonso-Navarro H, Benito-León J, Puertas I, Rubio L, López-Alburquerque T, Agúndez JA, Jiménez-Jiménez FJ.

Eur J Neurol. 2010 Jun 1;17(6):879-81. doi: 10.1111/j.1468-1331.2009.02914.x. Epub 2009 Dec 30.

PMID:
20050883
6.

Glyoxalase I A111E, paraoxonase 1 Q192R and L55M polymorphisms: susceptibility factors of multiple sclerosis?

Sidoti A, Antognelli C, Rinaldi C, D'Angelo R, Dattola V, Girlanda P, Talesa V, Amato A.

Mult Scler. 2007 May;13(4):446-53.

PMID:
17463067
7.

No association between genetic polymorphisms in NAD(P)H oxidase p22phox and paraoxonase 1 and colorectal cancer risk.

Van Der Logt EM, Janssen CH, Van Hooijdonk Z, Roelofs HM, Wobbes T, Nagengast FM, Peters WH.

Anticancer Res. 2005 Mar-Apr;25(2B):1465-70.

8.

Association of L55M and Q192R polymorphisms in paraoxonase 1 (PON1) gene with breast cancer risk and their clinical significance.

Hussein YM, Gharib AF, Etewa RL, ElSawy WH.

Mol Cell Biochem. 2011 May;351(1-2):117-23. doi: 10.1007/s11010-011-0718-4. Epub 2011 Jan 13.

PMID:
21229382
9.

Paraoxonase 1 gene polymorphisms contribute to coronary artery disease risk among north Indians.

Agrawal S, Tripathi G, Prajnya R, Sinha N, Gilmour A, Bush L, Mastana S.

Indian J Med Sci. 2009 Aug;63(8):335-44. doi: 10.4103/0019-5359.55884.

10.

Paraoxonase 1 gene polymorphisms and enzyme activities in diabetes mellitus.

Flekac M, Skrha J, Zídková K, Lacinová Z, Hilgertová J.

Physiol Res. 2008;57(5):717-26. Epub 2007 Oct 11.

11.

PON1 activity and genotype in patients with arterial ischemic stroke and in healthy individuals.

Schiavon R, Turazzini M, De Fanti E, Battaglia P, Targa L, Del Colle R, Fasolin A, Silvestri M, Biasioli S, Guidi G.

Acta Neurol Scand. 2007 Jul;116(1):26-30.

PMID:
17587252
12.

Human paraoxonase gene polymorphisms and coronary artery disease risk.

Mendonça MI, Dos Reis RP, Freitas AI, Sousa AC, Pereira A, Faria P, Gomes S, Silva B, Santos N, Serrão M, Ornelas I, Freitas S, Araújo JJ, Brehm A, Cardoso AA.

Rev Port Cardiol. 2008 Dec;27(12):1539-55. English, Portuguese.

13.

Analysis of paraoxonase 1 (PON1) genetic polymorphisms and activities as risk factors for ischemic stroke in Turkish population.

Demirdöğen BC, Demirkaya S, Türkanoğlu A, Bek S, Arinç E, Adali O.

Cell Biochem Funct. 2009 Dec;27(8):558-67. doi: 10.1002/cbf.1607.

PMID:
19902425
14.
15.

Paraoxonase gene polymorphisms and sporadic ALS.

Slowik A, Tomik B, Wolkow PP, Partyka D, Turaj W, Malecki MT, Pera J, Dziedzic T, Szczudlik A, Figlewicz DA.

Neurology. 2006 Sep 12;67(5):766-70. Epub 2006 Jul 5.

PMID:
16822965
16.

Paraoxonase polymorphisms PON1 192 and 55 and longevity in Italian centenarians and Irish nonagenarians. A pooled analysis.

Rea IM, McKeown PP, McMaster D, Young IS, Patterson C, Savage MJ, Belton C, Marchegiani F, Olivieri F, Bonafe M, Franceschi C.

Exp Gerontol. 2004 Apr;39(4):629-35.

PMID:
15050299
17.

Differential effects of paraoxonase 1 (PON1) polymorphisms on cancer risk: evidence from 25 published studies.

Fang DH, Fan CH, Ji Q, Qi BX, Li J, Wang L.

Mol Biol Rep. 2012 Jun;39(6):6801-9. doi: 10.1007/s11033-012-1505-3. Epub 2012 Feb 10.

PMID:
22322559
18.

Association of L55M and Q192R polymorphisms of paraoxonase-1 gene with preeclampsia.

Yaghmaei M, Hashemi M, Azarian A, Moazeni-Roodi A, Mokhtari M, Naghavai A, Salimi S, Mohammadi M, Taheri M, Ghavami S.

Arch Med Res. 2011 May;42(4):324-8. doi: 10.1016/j.arcmed.2011.06.006.

PMID:
21820612
19.

Mutations in the human paraoxonase 1 gene: frequencies, allelic linkages, and association with coronary artery disease.

Cascorbi I, Laule M, Mrozikiewicz PM, Mrozikiewicz A, Andel C, Baumann G, Roots I, Stangl K.

Pharmacogenetics. 1999 Dec;9(6):755-61.

PMID:
10634138
20.

Lack of association between paraoxonase 1 Q192R polymorphism and multiple sclerosis in relapse phase: A case-control study.

Moghtaderi A, Hashemi M, Sharafaddinzadeh N, Dabiri S, Moazeni-Roodi A, Ramroodi N, Zolfaghari M.

Clin Biochem. 2011 Jul;44(10-11):795-8. doi: 10.1016/j.clinbiochem.2011.04.010. Epub 2011 Apr 22.

PMID:
21545792
Items per page

Supplemental Content

Write to the Help Desk